125 related articles for article (PubMed ID: 10744036)
1. Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme.
Aziz T; Peress NS; Diaz A; Capala J; Chanana A
J Neuropathol Exp Neurol; 2000 Jan; 59(1):62-73. PubMed ID: 10744036
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
3. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
4. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
[TBL] [Abstract][Full Text] [Related]
5. Neuropathological postmortem evaluation of BNCT for GBM.
H-Stenstam B; Pellettieri L; Sköld K; Rezaei A; Brun A
Acta Neurol Scand; 2007 Sep; 116(3):169-76. PubMed ID: 17714330
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
Elowitz EH; Bergland RM; Coderre JA; Joel DD; Chadha M; Chanana AD
Neurosurgery; 1998 Mar; 42(3):463-8; discussion 468-9. PubMed ID: 9526978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
9. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
[TBL] [Abstract][Full Text] [Related]
10. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
11. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
[TBL] [Abstract][Full Text] [Related]
13. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
14. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
15. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
16. Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT.
Kageji T; Nagahiro S; Uyama S; Mizobuchi Y; Toi H; Nakamura M; Nakagawa Y
J Neurooncol; 2004 May; 68(1):25-32. PubMed ID: 15174518
[TBL] [Abstract][Full Text] [Related]
17. Cancer treatment. Will history repeat for boron capture therapy?
Flam F
Science; 1994 Jul; 265(5171):468-9. PubMed ID: 8036488
[No Abstract] [Full Text] [Related]
18. The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases.
Kawabata S; Miyatake S; Kajimoto Y; Kuroda Y; Kuroiwa T; Imahori Y; Kirihata M; Sakurai Y; Kobayashi T; Ono K
J Neurooncol; 2003 Nov; 65(2):159-65. PubMed ID: 14686736
[TBL] [Abstract][Full Text] [Related]
19. Boron self-shielding effects on dose delivery of neutron capture therapy using epithermal beam and boronophenylalanine.
Ye SJ
Med Phys; 1999 Nov; 26(11):2488-93. PubMed ID: 10587238
[TBL] [Abstract][Full Text] [Related]
20. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
